Protagonist Therapeutics Inc (PTGX)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 252,843 | 149,112 | 152,239 | 148,678 | -93,652 | -153,217 | -147,194 | -146,283 | -131,373 | -131,873 | -133,496 | -122,935 | -125,845 | -107,659 | -81,505 | -68,840 | -64,516 | -62,985 | -72,380 | -85,570 |
| Total assets | US$ in thousands | 744,725 | 603,857 | 614,629 | 629,276 | 357,951 | 330,016 | 320,466 | 239,858 | 247,928 | 282,174 | 310,512 | 348,296 | 347,695 | 373,175 | 404,232 | 298,072 | 324,468 | 217,320 | 224,980 | 134,901 |
| Operating ROA | 33.95% | 24.69% | 24.77% | 23.63% | -26.16% | -46.43% | -45.93% | -60.99% | -52.99% | -46.73% | -42.99% | -35.30% | -36.19% | -28.85% | -20.16% | -23.10% | -19.88% | -28.98% | -32.17% | -63.43% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $252,843K ÷ $744,725K
= 33.95%
Protagonist Therapeutics Inc's operating return on assets (ROA) has shown a fluctuating trend over the past few years. The company experienced negative operating ROA percentages ranging from -63.43% in March 2020 to -52.99% in December 2022. These negative values indicate that the company was not generating sufficient operating income relative to its total assets during this period.
However, there was a notable improvement in the company's performance starting from the first quarter of 2024. Protagonist Therapeutics Inc achieved positive operating ROA percentages of 23.63% in March 2024, which further increased to 33.95% in December 2024. These positive values suggest that the company was able to generate more operating income from its assets, indicating better efficiency and profitability in its operations during this period.
The significant improvement in Protagonist Therapeutics Inc's operating ROA from negative to positive values showcases a positive turnaround in the company's operational performance and asset utilization, indicating a potential increase in profitability and overall financial health.
Peer comparison
Dec 31, 2024